Dostarlimab, sold under the brand name Jemperli, is a mo...
wikipedia - 13 Jun 2022Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of endometrial cancer.[4][5][7][8][9]
Dostarlimab
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of endometrial cancer.[4][5][7][8][9]
Imfinzi, Keytruda Approved for Some Endometrial Cancers
NCI Cancer Bulletin - 06 Aug 2024Imfinzi, Keytruda Approved for Some Endometrial Cancers ...
Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer
OncLive - 07 Nov 2024Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer ...
Dostarlimab: Game Changer in Rectal Cancer Treatment?
Targeted Oncology - 17 Jun 2024Dostarlimab: Game Changer in Rectal Cancer Treatment? ...
A 100% response rate suggests dostarlimab is ‘definitive’ therapy for rectal cancer
Healio - 05 Jun 2024A 100% response rate suggests dostarlimab is ‘definitive’ therapy for rectal cancer ...
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer
Frontiers - 19 Jun 2024Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer ...
FDA Expands Approval of Dostarlimab for Advanced, Recurrent Endometrial Cancer
www.oncnursingnews.com/ - 01 Aug 2024FDA Expands Approval of Dostarlimab for Advanced, Recurrent Endometrial Cancer ...
Dostarlimab Benefits Appear More Pronounced in dMMR Endometrial Cancer
Cancer Network - 16 Aug 2024Dostarlimab Benefits Appear More Pronounced in dMMR Endometrial Cancer ...
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
Business Wire - 01 Aug 2024US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit ...
Dostarlimab Plus Chemotherapy Opens Doors Across Endometrial Cancer Subtypes
OncLive - 23 Aug 2024Dostarlimab Plus Chemotherapy Opens Doors Across Endometrial Cancer Subtypes ...
Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinoma
Frontiers - 24 Jun 2024Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinoma ...
Dostarlimab Earns FDA Priority Review in All Advanced Endometrial Cancers
Cancer Network - 24 Apr 2024Dostarlimab Earns FDA Priority Review in All Advanced Endometrial Cancers ...
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer
OncLive - 03 Jul 2024Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer ...
Dostarlimab/Chemotherapy Under EMA Review for Primary Advanced/Recurrent Endometrial Cancer
OncLive - 24 Jun 2024Dostarlimab/Chemotherapy Under EMA Review for Primary Advanced/Recurrent Endometrial Cancer ...
Frontline Dostarlimab/Chemo Maintains Numerical OS Benefit in Advanced NSCLC
OncLive - 08 Nov 2024Frontline Dostarlimab/Chemo Maintains Numerical OS Benefit in Advanced NSCLC ...
Dostarlimab/Chemo/Niraparib Generates PFS Benefit in Primary/Recurrent Endometrial Cancer
OncLive - 25 Jun 2024Dostarlimab/Chemo/Niraparib Generates PFS Benefit in Primary/Recurrent Endometrial Cancer ...
FDA Approval Insights: Dostarlimab Plus Chemotherapy in Advanced/Recurrent Endometrial Cancer
OncLive - 26 Aug 2024FDA Approval Insights: Dostarlimab Plus Chemotherapy in Advanced/Recurrent Endometrial Cancer ...
Dostarlimab Wins Full Approval in Canada for dMMR/MSI-H Endometrial Cancer
OncLive - 25 Jul 2024Dostarlimab Wins Full Approval in Canada for dMMR/MSI-H Endometrial Cancer ...
Dr Chase on the FDA Approval of Dostarlimab Plus Chemotherapy in Endometrial Cancer
OncLive - 30 Aug 2024Dr Chase on the FDA Approval of Dostarlimab Plus Chemotherapy in Endometrial Cancer ...
Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer
OncLive - 05 Dec 2024Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer ...
What's New
- The Story of Machine Gun Kelly and Megan Fox's Whirlwind ...
- Sen. Mitch McConnell is 'fine' after medical personnel spotted at his ...
- DeMarvion Overshown injury: 2025 season in jeopardy, per Mike ...
- Champions League as it happened: Real Madrid win in thriller - ESPN
- Who are Jay-Z's children, Blue Ivy, Rumi and Sir?
- Taylor Lorenz's sympathy with suspected UnitedHealthcare CEO ...
- Gracie Abrams Announces The Secret Of Us Deluxe Tour
- In memoriam: Nikki Giovanni, renowned poet, activist, and Virginia ...
- Joe Burrow's house burglarized while he was away for MNF game
- Bengals Defeat Cowboys 27-20 | POSTGAME RECAP, NOTES ...
- Jerry Jones: Cowboys 'devastated' by blocked punt mistake vs ...
- Bengals-Cowboys: Ja'Marr Chase, Cincinnati take advantage of Leon Lett-like Dallas blunder in stunning win